Altimmune (ALT) Current Taxes (2016 - 2022)
Altimmune (ALT) reported Current Taxes of $1.2 million for Q3 2022, down 62.98% on a QoQ basis from $3.2 million in Q4 2016.
Altimmune (ALT) has 2 years of Current Taxes data on file, last reported at $1.2 million in Q3 2022.
- Quarterly Current Taxes changed N/A year-over-year to $1.2 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $1.2 million (changed N/A YoY) and the FY2016 annual result came in at $3.2 million, changed N/A from the prior year.
- Current Taxes eased to $1.2 million in Q3 2022 per ALT's latest filing, from $3.2 million in the prior quarter.
- Across five years, Current Taxes topped out at $1.2 million in Q3 2022 and bottomed at $1.2 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.17 Mn |
| Dec 31, 2016 | 3.16 Mn |